Related Experiment Video

Updated: Apr 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Cardiac sarcoidosis: diagnosis and management

S W Dubrey1, R Sharma2, R Underwood3

  • 1Department of Cardiology, Hillingdon Hospital, Uxbridge, UK.

Postgraduate Medical Journal
|July 2, 2015
PubMed

Insights

Cardiac sarcoidosis, a serious heart condition, presents unpredictably with arrhythmias or heart failure. Advanced imaging and tailored treatments, including corticosteroids, are crucial for managing this variable disease.

Area of Science:

  • Cardiology
  • Immunology
  • Internal Medicine

Background:

  • Cardiac sarcoidosis is a severe manifestation of sarcoidosis, impacting the heart.
  • It often leads to arrhythmias, conduction disease, or heart failure.
  • Prognosis varies significantly due to heterogeneous presentation and racial differences.

Purpose of the Study:

  • To review the epidemiology of cardiac sarcoidosis.
  • To discuss advancements in diagnostic techniques.
  • To outline current management strategies for cardiac sarcoidosis.

Main Methods:

  • Review of existing literature on cardiac sarcoidosis.
  • Analysis of diagnostic modalities including ECG, echocardiography, PET, MRI, and nuclear scanning.
  • Evaluation of treatment approaches, from corticosteroids to immunosuppressants and heart transplantation.

Main Results:

  • Cardiac involvement presents with diverse symptoms like arrhythmias and heart failure.
  • Advanced imaging (PET, MRI) is essential for diagnosis and management.
  • Corticosteroids are the primary treatment, with other therapies and heart transplantation as options.

Conclusions:

  • Cardiac sarcoidosis diagnosis and management remain challenging, especially for subclinical cases.
  • Early and accurate diagnosis using advanced imaging is vital.
  • Treatment strategies are evolving, with heart transplantation offering a viable option in select cases.

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
852
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
326
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
467
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
536